ADUS vs INNV
ADUS: Home-based personal care, hospice, and home health provider serving dual-eligible elderly and infirm consumers across 23 states with a model that reduces overall healthcare costs while improving quality and consumer satisfaction. INNV: InnovAge operates integrated primary care and chronic disease management centers under the PACE model for frail elderly populations, earning capitated fees from government payors.
Side-by-side fundamentals
| Metric | ADUS | INNV | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $111.40 | $11.68 | |
| Market cap as of 2026-07-23 | $2.1B | $1.6B | |
| P/E as of 2026-07-23 | 21.14 | n/a | |
| PEG as of 2026-07-23 | 2.48 | n/a | |
| Net margin as of 2026-07-23 | +6.9% | -1.2% | ADUS higher |
| Gross margin as of 2026-07-23 | +32.5% | +21.8% | ADUS higher |
| Operating margin as of 2026-07-23 | +9.8% | -1.0% | ADUS higher |
| ROE as of 2026-07-23 | +9.3% | -4.8% | ADUS higher |
| ROA as of 2026-07-23 | +7.0% | -2.2% | ADUS higher |
| Debt / equity as of 2026-07-23 | 0.08 | 0.30 | ADUS lower |
| Revenue growth (YoY) as of 2026-07-23 | +19.6% | +14.1% | ADUS higher |
| Revenue CAGR (3y) SEC XBRL | +14.4% | +6.9% | ADUS higher |
| Beta as of 2026-07-23 | 0.87 | 0.38 | |
| 1-year return as of 2026-07-22 close | +5.5% | +211.6% | INNV higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.